1. Contact details
Name of organisation
1) Department/Research groupDAPI
2) Organisation/affiliationDeutsches Arzneiprüfungsinstitut e.V. (DAPI)
Short Name in the inventoryDAPI
Administrative Contact
Title Ms
Last name Werning
First name Johanna
Address line 1Heidestraße 7
Address line 2
Address line 3
CityBerlin
Postcode10557
CountryGermany
Phone number (incl. country code)49-30-40004572
Alternative phone number
Fax number (incl. country code)49-30-40004573
Scientific Contact
Title Ms
Last name Werning
First name Johanna
Address line 1Heidestraße 7
Address line 2
Address line 3
CityBerlin
Postcode10557
CountryGermany
Phone number (incl. country code)49-30-40004572
Alternative phone number
Fax number (incl. country code)49-30-40004573
Alternative Scientific Contact
Title Ms
Last name Kieble
First name Marita
Address line 1Heidestraße 7
Address line 2
Address line 3
CityBerlin
Postcode10557
CountryGermany
Phone number (incl. country code)49-30-40004572
Alternative phone number
Fax number (incl. country code)49-30-40004573
2. Description
The German Institute for Drug Use Evaluation (Deutsches Arzneiprüfungsinstitut e. V. (DAPI)) is a non-profit association active in the area of pharmacoepidemiology and pharmacoeconomics.
The DAPI operates a database comprising anonymous claims data of prescribed medicinal products dispensed at community pharmacies in the Federal Republic of Germany at the expense of the statutory health insurance (GKV) funds. Roughly 90 % of Germany's population is insured by this system (approx. 70 million people).
3. Category
Charity or non-profit organisation
4. Available resources
In houseVia Contacts/Network
Epidemiologist/Pharmacoepidemiologist
Yes
No
Statistician
Yes
No
Pharmacist
Yes
No
IT specialist
Yes
No
Legal expertise
No
Yes
5. Therapeutic/disease areas of research in drug safety/risk-benefit performed in the past 5 years
Cardiovascular diseases
Geriatrics
Immunological products and vaccines
Infectious diseases
Photosensitizing drugs
Biosimilars
Opioids
6. Design of drug safety/risk-benefit studies published in the past 5 years
Cohort Study
Drug Utilisation
7. Experience in collecting data directly from individual patients/respondents
None
8. Access to data collection resources
Capacity to conduct face-to-face interviews
No
Electronic data capture systems
No
Interactive voice response systems
No
Call centre
No